Related Experiment Video

Updated: Aug 19, 2026

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System
07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System

Published on: May 5, 2018

Genetics and cardiovascular disease

Ronald T Acton1, Rodney C P Go, Jeffrey M Roseman

  • 1Department of Microbiology, Immunogenetics Program, University of Alabama at Birmingham, Alabama 35294-0005, USA. acton@uab.edu

Ethnicity & Disease
|February 24, 2005
PubMed

Insights

Assessing family history and genetic factors is crucial for understanding cardiovascular disease (CVD) risk. Genetic profiling aids in prognosis, prevention, and targeted treatments for CVD.

Area of Science:

  • Genetics and Cardiovascular Health

Background:

  • Cardiovascular disease (CVD) arises from complex interactions between genetic, lifestyle, and environmental factors.
  • Family history of CVD is a valuable indicator of shared genetic, environmental, and lifestyle influences, aiding in risk assessment.

Purpose of the Study:

  • To highlight the importance of family history in estimating cardiovascular disease risk.
  • To present methods for identifying genetic variants involved in CVD etiology, including the candidate gene approach.
  • To discuss the role of genetic profiling in CVD prognosis, prevention, and treatment.

Main Methods:

  • Reviewing the utility of family history assessment for cardiovascular disease risk.
  • Presenting the candidate gene approach for identifying genetic risk factors in coronary heart disease.
  • Discussing the application of genetic profiling for personalized cardiovascular medicine.

Main Results:

  • Family history provides significant insights into an individual's predisposition to cardiovascular disease.
  • The candidate gene approach has been employed to identify specific genetic risk factors for coronary heart disease.
  • Genetic profiling offers potential for predicting prognosis, tailoring preventive measures, and optimizing drug selection for CVD.

Conclusions:

  • Integrating family history and genetic information is essential for comprehensive cardiovascular disease risk assessment.
  • Genetic profiling holds promise for advancing personalized strategies in cardiovascular disease prevention and treatment.
  • Further exploration of genetic factors and novel approaches is necessary for a deeper understanding of complex cardiovascular diseases.

More Related Videos

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods08:28

Analysis of Congenital Heart Defects in Mouse Embryos Using Qualitative and Quantitative Histological Methods

Published on: March 10, 2020

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...